NEA Management Company, LLC - Q3 2020 holdings

$2.36 Billion is the total value of NEA Management Company, LLC's 54 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 25.0% .

 Value Shares↓ Weighting
SPT SellSPROUT SOCIAL INC$215,449,000
-11.8%
5,596,080
-38.1%
9.12%
-7.1%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$132,988,000
-13.4%
1,590,002
-23.9%
5.63%
-8.8%
MRSN SellMERSANA THERAPEUTICS INC$110,966,000
-40.4%
5,959,520
-25.1%
4.70%
-37.3%
NET SellCLOUDFLARE INC$11,347,000
-92.2%
2,763,583
-31.9%
0.48%
-91.8%
SENS SellSENSEONICS HOLDINGS INC$5,520,000
-11.7%
14,153,201
-11.7%
0.23%
-6.8%
SNSS SellSUNESIS PHARMACEUTICALS INC$162,000
-52.6%
129,827
-90.0%
0.01%
-50.0%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-3,243,150
-100.0%
-0.24%
DZSI ExitDASAN ZHONE SOLUTIONS INC$0-956,255
-100.0%
-0.34%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings